^ 'Cadila Pharma inks pact with Norwegian start-up to develop new treatment for heart patients'.^ 'Cadila Pharmaceuticals launches Polycap, which reduces cardiovascular and stroke risk substantially'.^ 'Cadila launches new drug for TB treatment'.'Cadila Pharma unveils acidity drug in IV form' вЂ“ via Business Standard. ^ Bureau, Our Regional (16 July 2004).

Archived from the original on 21 April 2014. Archived from the original on 7 July 2014.

'Carrying the legacy forward: Rajiv Modi' вЂ“ via Business Standard. CPhI Worldwide - Uniting the Pharmaceutical Industry. Great Place to Work Certified, 2020 References Observenow Future of Workplace Award, 2019 Most Trusted Companies of 2008, Sara Media and Zee Business In 2019, Cadila Pharmaceuticals formed a partnership with Norwegian start-up, Serca Pharmaceuticals to develop new treatment for heart patients. Some of the top brands of the company are Aciloc, Envas, Calcirol, Haem Up, Vasograin, Tricort, Fludac, Rabiloc, Trigan-D, Mycobutol and Sepsivac. ДЇor the patients suffering from Non Small Cell Lung Cancer (NSCLC), company has recently introduced вЂMycidac-CвЂ™ - first in the class active immunotherapy as well as drug targeting Desmocollin. In 2009, the worldвЂ™s first boosted-Rifampicin fixed-dose combination for the treatment of Tuberculosis вЂ“ вЂRisorineвЂ™ and world's first drug combination for prevention of Cardiovascular Diseases вЂ“ вЂ PolycapвЂ™ were introduced by Cadila Pharmaceuticals. The company was also the first in the world to introduce Rabeprazole in IV form вЂ“ вЂRabelocвЂ™. Products and services Д¬adila Pharmaceuticals is the only Indian manufacturer of natural Streptokinase and Hyaluronic Acid products. Д¬adila Pharmaceuticals has connections with various institutions for research Department of Biotechnology, UDSC, New Delhi IISc, Bangalore Lala Ram Sarup Institute of TB & Respiratory diseases, New Delhi RRL, Jammu CSIR, New Delhi CDRI, Lucknow Advanced Transfusion Medicine Research Foundation, Ahmedabad National Institute of Immunology, New Delhi Institute of Microbial Technology, Chandigarh Talwar Research Foundation, New Delhi and Trieste, Italy. The company has five IND dossiers filed with the USFDA for pulmonary tuberculosis, lung cancer, prostate cancer, bladder cancer and melanoma. area at Dholka, Gujarat, India which is manned by 300 scientists. Research Д¬adila Pharmaceuticals has established a dedicated R&D facility, spread over 1,05,000 sq. The manufacturing facility at Dholka and the API unit at Ankleshwar in Gujarat are USFDA-certified the overseas manufacturing facility at Ethiopia is the WHO - cGMP compliant facility. Operations Д¬adila Pharmaceuticals has its formulation manufacturing facilities at Dholka, Gujarat (India) Samba, Jammu (India) and at Addis Ababa (Ethiopia) and 2 API manufacturing facilities are located at Ankleshwar, Gujarat. Rajiv Modi and I A Modi worked closely to run Cadila Pharma, now considered one of the largest privately-held pharma companies in the country. Ramanbhai Patel and his son Pankaj Patel family).

Rajiv Modi) and Cadila Healthcare (owned by Shri. The Modi and Patel families decided to split the business in 1995, two entities were formed - Cadila Pharmaceuticals Ltd (owned and controlled by Shri. The company that started in a rented bungalow with a capital of Rs 25,000 and achieved a turnover of around Rs 1.25 lakh in its first year of operation had come a long way. In 1951 Indravadan A Modi had quit his job as a chemist in a Mumbai firm to start Cadila Laboratories with childhood friend Ramanbhai Patel. Indravadan Modi, Founder Cadila Laboratories

Trigan d india